[Secondary glomerular nephropathies].
Secondary glomerular lesions are associated with various diseases; diabetes, systemic lupus erythematosus, primary cryoglobulinaemia, cryoglobulinemia and membranoproliferative glomerulonephritis secondary to hepatitis C virus (HCV), ANCA associated vasculitis and their forms limited to kidney (necrotic and crescentic GN), Goodpasture syndrome, HIV associated nephropathies, AL amyloidosis, AA amyloidosis (secondary amyloidosis), GN with non-amyloid organised deposits.
Lesavre
Philippe
P
Service de néphrologie et INSERM U507, hôpital Necker, 75743 Paris Cedex 15. lesavre@necker.fr
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000419:Albuminuria / Q000175:diagnosis; D000686:Amyloidosis / Q000150:complications; D019380:Anti-HIV Agents / Q000627:therapeutic use; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000032:analysis; D001706:Biopsy; D003449:Cryoglobulinemia / Q000150:complications; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003928:Diabetic Nephropathies / Q000175:diagnosis / Q000517:prevention & control; D003937:Diagnosis, Differential; D005921:Glomerulonephritis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000473:pathology / Q000628:therapy; D015433:Glomerulonephritis, Membranous / Q000209:etiology; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000473:pathology; D007674:Kidney Diseases / Q000150:complications; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008181:Lupus Nephritis / Q000209:etiology; D010956:Plasmapheresis; D011379:Prognosis; D013577:Syndrome; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D019380:Anti-HIV Agents; D019268:Antibodies, Antineutrophil Cytoplasmic; D007166:Immunosuppressive Agents